Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cash from Financing Activities (2016 - 2025)

Ironwood Pharmaceuticals' Cash from Financing Activities history spans 16 years, with the latest figure at $122000.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 100.82% to $122000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $216000.0, a 100.2% increase, with the full-year FY2025 number at $216000.0, up 100.2% from a year prior.
  • Cash from Financing Activities hit $122000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from $88000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for IRWD hit a ceiling of $399.1 million in Q2 2023 and a floor of -$150.3 million in Q2 2022.
  • Historically, Cash from Financing Activities has averaged -$3.8 million across 5 years, with a median of $6000.0 in 2025.
  • Biggest five-year swings in Cash from Financing Activities: soared 820.0% in 2021 and later crashed 9508.78% in 2023.
  • Tracing IRWD's Cash from Financing Activities over 5 years: stood at -$18.6 million in 2021, then surged by 115.1% to $2.8 million in 2022, then crashed by 1914.11% to -$50.9 million in 2023, then soared by 70.75% to -$14.9 million in 2024, then soared by 100.82% to $122000.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for IRWD at $122000.0 in Q4 2025, $88000.0 in Q2 2025, and $6000.0 in Q1 2025.